RAHWAY, N.J., March 6, 2025 /PRNewswire/ -- A sinus infection, known as sinusitis, is one of the most common medical conditions. But in some cases, it can come with dangerous complications.

Merck & Co has entered into a worldwide licensing ... gets better in a few weeks without treatment. After infection, the virus becomes latent in the body, however, and can be a trigger for some ...

Human metapneumovirus is a leading cause of acute respiratory infection ... according to Merck Manual, a popular reference for doctors and pharmacists. Tips for avoiding the virus are the same ...

On Wednesday, Merck & Co Inc (NYSE:MRK) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection ... ISL had a viral load ...

In trial MK-8591A-052, 91.5% on DOR/ISL maintained viral suppression at Week 48 vs ... data from both studies in December 2024. Also Read: Merck Injects $1 Billion To Expand Vaccine Production ...

On Wednesday, Merck & Co Inc (NYSE:MRK) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection that is virologically ...